| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/13/1999 | US5922740 Antiinflammatory agents |
| 07/13/1999 | US5922734 Novel compounds for treating psoriasis and methods for their synthesis |
| 07/13/1999 | US5922701 Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| 07/13/1999 | US5922700 Kit for drug delivery of steroids |
| 07/13/1999 | US5922571 Polynucleotides encoding a protein kinase C homolog |
| 07/13/1999 | US5922314 Skin preparation composition |
| 07/13/1999 | US5922313 Lotion consists of a mixture of polyvinylpyrrolidone and hydroxyethyl cellulose, an antibacterial agent chlorhexidine digluconate or 2,4,4'-trichloro-2'-hydroxydiphenylether, blend of glyceryl stearate and polyethylene glycol emulsifer |
| 07/13/1999 | US5922305 Methods of treating tissues with oxygen-supersaturated emulsions |
| 07/13/1999 | US5922302 Detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates |
| 07/13/1999 | CA2258445A1 Compositions for the reduction of scarring |
| 07/13/1999 | CA2159985C Methods of using hesperetin for sebum control and treatment of acne |
| 07/13/1999 | CA2148074C Cosmetic or pharmaceutical composition for topical use |
| 07/13/1999 | CA2146212C Cosmetic or pharmaceutical composition containing an alkyl carbamate as a hydrating agent |
| 07/13/1999 | CA2135999C Biotherapeutic cell-coated microspheres |
| 07/13/1999 | CA2131477C Cosmetic or dermatological composition containing an oil-in-water emulsion made of oily globules coated with a stratified liquid crystalline layer |
| 07/08/1999 | WO1999033851A1 N-het-substituted glycerophosphoethanolamines |
| 07/08/1999 | WO1999033834A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | WO1999033828A1 Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 07/08/1999 | WO1999033827A1 Novel imidazole derivatives |
| 07/08/1999 | WO1999033821A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 07/08/1999 | WO1999033789A1 SUBSTITUTED β-ALANINES |
| 07/08/1999 | WO1999033786A1 Anti-inflammatory compounds |
| 07/08/1999 | WO1999033485A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | WO1999025686B1 Cyclic amine derivatives and their use as drugs |
| 07/08/1999 | CA2316235A1 Substituted .beta.-alanines |
| 07/08/1999 | CA2315977A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | CA2315144A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | CA2315055A1 Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927554A2 Cosmetic composition for skin comprising urea |
| 07/07/1999 | EP0927254A1 Antagonists of interleukin-15 |
| 07/07/1999 | EP0927217A1 Angiogenic inhibitory compounds |
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927191A2 Anti-inflammatory peptides and uses thereof |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927168A1 1,3-diheterocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927167A1 2-phenyl benzimidazole derivatives as mcp-1 antagonists |
| 07/07/1999 | EP0927161A1 Substituted cyclic amine metalloprotease inhibitors |
| 07/07/1999 | EP0927156A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/07/1999 | EP0927053A1 Fragmented polymeric hydrogels for adhesion prevention and their preparation |
| 07/07/1999 | EP0927033A1 Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases |
| 07/07/1999 | EP0805807B1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-(1)benzopyran for treating proliferative disorders |
| 07/07/1999 | EP0580803B1 Antimicrobial compositions useful for medical applications |
| 07/07/1999 | EP0500807B1 Tissue moisturizing composition and method |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/07/1999 | CN1222160A Pregnane derivatives with no alpha-17 substitutent, their medicinal use, mfg. method and its intermediaries and related compounds |
| 07/07/1999 | CN1221625A Oral medicine for treating beri-beri |
| 07/06/1999 | US5919960 Phytosphingosine-based ceramide I analogs |
| 07/06/1999 | US5919943 Inhibition of spla2 |
| 07/06/1999 | US5919810 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |
| 07/06/1999 | US5919773 Antisense oligonucleotide modulation of raf gene expression |
| 07/06/1999 | US5919702 Collecting wharton's jelly from umbilical cords, culturing so that pre-chondrocytes proliferate, isolating pre-chondrocytes which give rise to chondrocytes which produce cartilage tissue for therapeutic use |
| 07/06/1999 | US5919660 Human requiem |
| 07/06/1999 | US5919615 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 07/06/1999 | US5919438 Combinatory immixture of (a) at least one antifungal agent and (b) at least one halogenated antibacterial agent other than a macrolide or pyranoside |
| 07/06/1999 | CA2098397C Physiologically active substance designated as epimorphin, genes encoding the same, and antibodies thereto |
| 07/06/1999 | CA2082296C Process for the preparation of stable, complex emulsion systems of the water-oil-type and their use as cosmetic preparations |
| 07/01/1999 | WO1999032634A2 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | WO1999032614A1 Secreted proteins and polynucleotides encoding them |
| 07/01/1999 | WO1999032514A2 Sag: sensitive to apoptosis gene |
| 07/01/1999 | WO1999032452A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 07/01/1999 | WO1999032451A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals |
| 07/01/1999 | WO1999032152A2 Methods for delivering pharmaceutical agents to mucosal surfaces |
| 07/01/1999 | WO1999032151A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| 07/01/1999 | WO1999032135A1 Keratinocyte growth factor-2 formulations |
| 07/01/1999 | WO1999032125A1 Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 07/01/1999 | WO1999032111A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
| 07/01/1999 | WO1999032105A1 Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof |
| 07/01/1999 | WO1999032099A2 Use of fucane for regulating the reconstruction of connective tissues |
| 07/01/1999 | WO1999032098A2 Combination of a ramba and a tocopherol |
| 07/01/1999 | WO1999032084A1 Compositions for the treatment of skin and anorectal conditions |
| 07/01/1999 | WO1999032077A1 Use of amino phenol amide derivatives as depigmentation agents |
| 07/01/1999 | WO1999032072A1 Compositions and methods for treatment of alopecia |
| 07/01/1999 | WO1999031987A1 Topical carbamazepine formulations and methods of use |
| 07/01/1999 | WO1999020121A3 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |
| 07/01/1999 | CA2316248A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| 07/01/1999 | CA2316015A1 Keratinocyte growth factor-2 formulations |
| 07/01/1999 | CA2315720A1 Inhibition of p38 kinase activity using substituted heterocyclic ureas |
| 07/01/1999 | CA2315539A1 Compositions derived from mycobacterium vaccae and methods for their use |
| 07/01/1999 | CA2315245A1 Secreted proteins and polynucleotides encoding them |
| 07/01/1999 | CA2314868A1 Topical carbamazepine formulations and methods of use |
| 07/01/1999 | CA2303483A1 Sag: sensitive to apoptosis gene |
| 07/01/1999 | CA2280950A1 Use of amino phenol amide derivatives as depigmentation agents |
| 06/30/1999 | EP0926148A1 Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors |
| 06/30/1999 | EP0925783A1 Skin protection preparation |
| 06/30/1999 | EP0925781A1 Skin whitening composition |
| 06/30/1999 | EP0925779A1 Cosmetic composition containing cinnamic acid or at least a derivative and its use |
| 06/30/1999 | EP0925359A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 06/30/1999 | EP0925303A1 Phosphinic acid amides as matrix metalloprotease inhibitors |
| 06/30/1999 | EP0925287A1 Heterocyclic metalloprotease inhibitors |
| 06/30/1999 | EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 06/30/1999 | CN1221342A Oxa acids and related compounds for treating skin conditions |
| 06/30/1999 | CN1221334A Detergent composition for skin |
| 06/30/1999 | CN1220884A Traditional Chinese medicine preparation for treatment of skin disease and running sore and carbuncle |
| 06/30/1999 | CN1043883C Vitamin D analogues, medicinal composition containing the same and medical use thereof |
| 06/29/1999 | US5917088 Salicyclic acid derivatives, process of preparation and uses thereof |
| 06/29/1999 | US5916918 Bedsore |
| 06/29/1999 | US5916889 1,4-disubstituted piperazines |
| 06/29/1999 | US5916885 Treatment of psoriasis, dermatitis |